Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation

Experimental Hematology

Volumn 35, Issue 2, 2007, Pages 184-192

  Imanguli, Matin M ^a   Atkinson, Jane C ^a   Harvey, Kristen E ^a   Hoehn, Gerard T ^a   Ryu, Ok Hee ^a   Wu, Tianxia ^b   Kingman, Albert ^b   Barrett, A John ^c   Bishop, Michael R ^d   Childs, Richard W ^c   Fowler, Daniel H ^d   Pavletic, Steven Z ^d   Hart, Thomas C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; LACTOFERRIN; PROTEOME; SALIVA PROTEIN; SECRETORY IMMUNOGLOBULIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; SALIVA; STATISTICAL SIGNIFICANCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; BETA 2-MICROGLOBULIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN A; LACTOFERRIN; MALE; MULTIVARIATE ANALYSIS; PROTEOME; SALIVA; SALIVARY PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846350951     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.10.009     Document Type: Article

References (41)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
2. Eisen D., Essell J., and Broun E.R. Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 16 (1997) 265-272
3. Epstein J.B., Tsang A.H., Warkentin D., and Ship J.A. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 (2002) 39-44
4. Ruescher T.J., Sodeifi A., Scrivani S.J., Kaban L.B., and Sonis S.T. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82 (1998) 2275-2281
5. Costa S.F., Miceli M.H., and Anaissie E.J. Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?. Lancet Infect Dis 4 (2004) 278-286
6. Schultz K.R., Miklos D.B., Fowler D., et al. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol Blood Marrow Transplant 12 (2006) 126-137
7. Mandel I.D. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 119 (1989) 298-304
8. Amerongen A.V., and Veerman E.C. Saliva-the defender of the oral cavity. Oral Dis 8 (2002) 12-22
9. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
10. Yang D., Chertov O., Bykovskaia S.N., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
11. Biragyn A., Ruffini P.A., Leifer C.A., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298 (2002) 1025-1029
12. Dens F., Boogaerts M., Boute P., Declerck D., Demuynck H., and Vinckier F. Quantitative determination of immunological components of salivary gland secretion in transplant recipients. Bone Marrow Transplant 17 (1996) 421-423
13. Fox P.C., van der Ven P.F., Sonies B.C., Weiffenbach J.M., and Baum B.J. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 110 (1985) 519-525
14. Ryu O.H., Atkinson J.C., Hoehn G.T., Illei G.G., and Hart T.C. Identification of parotid salivary biomarkers in Sjögren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 45 (2006) 1077-1086
15. Neuhoff V., Arold N., Taube D., and Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9 (1988) 255-262
16. Williams S.E., Brown T.I., Roghanian A., and Sallenave J.M. SLPI and elafin: one glove, many fingers. Clin Sci (Lond) 110 (2006) 21-35
17. 2-microglobulin in lymphoproliferative and myeloproliferative diseases. Hematol Oncol 2 (1984) 391-401
18. 2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med 293 (1975) 1228-1231
19. Sale G.E., Shulman H.M., Schubert M.M., et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 12 (1981) 1022-1030
20. Tang N., Tornatore P., and Weinberger S.R. Current developments in SELDI affinity technology. Mass Spectrom Rev 23 (2004) 34-44
21. Srinivasan R., Daniels J., Fusaro V., et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp Hematol 34 (2006) 796-801
22. Kaiser T., Kamal H., Rank A., et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104 (2004) 340-349
23. Van den Bergh G., and Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 15 (2004) 38-43
24. Ward P.P., Uribe-Luna S., and Conneely O.M. Lactoferrin and host defense. Biochem Cell Biol 80 (2002) 95-102
25. Kimber I., Cumberbatch M., Dearman R.J., Headon D.R., Bhushan M., and Griffiths C.E. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 80 (2002) 103-107
26. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285 (1999) 412-415
27. Konttinen Y.T., Kulomaa M., Malmstrom M., Kilpi A., and Reitamo S. Lactoferrin in Sjögren's syndrome. Arthritis Rheum 27 (1984) 462-467
28. Dickinson D.P. Salivary (SD-type) cystatins: over one billion years in the making-but to what purpose?. Crit Rev Oral Biol Med 13 (2002) 485-508
29. McNeely T.B., Dealy M., Dripps D.J., Orenstein J.M., Eisenberg S.P., and Wahl S.M. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 96 (1995) 456-464
30. Ashcroft G.S., Lei K., Jin W., et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 6 (2000) 1147-1153
31. Jin F.Y., Nathan C., Radzioch D., and Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88 (1997) 417-426
32. Nakamura A., Mori Y., Hagiwara K., et al. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 197 (2003) 669-674
33. Cooke K.R., Hill G.R., Crawford J.M., et al. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 102 (1998) 1882-1891
34. Hill G.R., Crawford J.M., Cooke K.R., Brinson Y.S., Pan L., and Ferrara J.L. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90 (1997) 3204-3213
35. Johansen F.E., Pekna M., Norderhaug I.N., et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med 190 (1999) 915-922
36. Bortner C.A., Miller R.D., and Arnold R.R. Effects of alpha-amylase on in vitro growth of Legionella pneumophila. Infect Immun 41 (1983) 44-49
37. Jespersgaard C., Hajishengallis G., Russell M.W., and Michalek S.M. Identification and characterization of a nonimmunoglobulin factor in human saliva that inhibits Streptococcus mutans glucosyltransferase. Infect Immun 70 (2002) 1136-1142
38. Voss E., Wehkamp J., Wehkamp K., Stange E.F., Schroder J.M., and Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281 (2006) 2005-2011
39. Wehkamp J., Fellermann K., Herrlinger K.R., et al. Human beta-defensin-2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14 (2002) 745-752
40. Holler E., Rogler G., Brenmoehl J., et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 107 (2006) 4189-4193
41. Holler E., Rogler G., Herfarth H., et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104 (2004) 889-894